Daily Cosmetic Research Analysis
Today's most impactful cosmetic-related research spans clinical dermatology, oral-care microbiome science, and environmental safety. A pooled phase 3 RCT confirms the efficacy of sofpironium gel for primary axillary hyperhidrosis, a zinc-citrate toothpaste RCT shows in-vivo modulation of plaque microbiome composition and function, and mechanistic toxicology reveals photodegradation amplifies the cytotoxicity of sunscreen-derived microplastics via leachates.
Summary
Today's most impactful cosmetic-related research spans clinical dermatology, oral-care microbiome science, and environmental safety. A pooled phase 3 RCT confirms the efficacy of sofpironium gel for primary axillary hyperhidrosis, a zinc-citrate toothpaste RCT shows in-vivo modulation of plaque microbiome composition and function, and mechanistic toxicology reveals photodegradation amplifies the cytotoxicity of sunscreen-derived microplastics via leachates.
Research Themes
- Dermatologic therapeutics for quality-of-life conditions
- Oral-care microbiome modulation by consumer products
- Environmental safety of cosmetic ingredients and carriers
Selected Articles
1. Photodegradation Controls of Potential Toxicity of Secondary Sunscreen-Derived Microplastics and Associated Leachates.
Using combined mechanical and photodegradation, the study shows that photodegradation of sunscreen-derived microplastics drives chemical transformations that increase intracellular sequestration and leachate toxicity, with mitochondrial fragmentation as a key biomarker. Non-targeted HRMS identified 46 plastic-associated leachate compounds, implicating additive dissociation and oxidative conversion in cytotoxicity.
Impact: Elucidates a mechanistic basis for increased toxicity of sunscreen-derived microplastics after photodegradation, informing safer cosmetic formulation and environmental policy.
Clinical Implications: Dermatology and primary care can counsel on reef-safe, microplastic-minimizing sunscreens and support policies to limit harmful additives; industry can prioritize formulations less prone to toxic leachates post-UV exposure.
Key Findings
- Photodegradation, beyond mechanical fragmentation, introduced oxidation, bond scission, and cross-linking in secondary sunscreen-derived microplastics.
- Both physical fragmentation and photooxidation increased intracellular sequestration of microplastics; leachate toxicity was primarily driven by photochemical transformations.
- Non-targeted HRMS identified 46 plastic-associated compounds in leachates; photodegradation facilitated dissociation of hydrophobic additives and oxidative conversion.
- Mitochondrial fragmentation was the primary subcellular biomarker indicating leachate-induced cytotoxicity.
Methodological Strengths
- Integrated photomechanical degradation with multi-omics analytics (pyrolysis GC-MS, non-targeted HRMS) to map chemical transformations.
- Cellular assays linked physicochemical changes to specific toxicity biomarkers (mitochondrial fragmentation).
Limitations
- Findings are based on in vitro cellular models and may not fully capture in vivo ecological or human exposure contexts.
- Specific sunscreen polymers/additives tested may limit generalizability across all cosmetic formulations and environmental conditions.
Future Directions: Test broader polymer/additive chemistries under realistic UV and environmental conditions, quantify human/environmental exposure, and develop safer-by-design cosmetic carriers.
The escalating environmental concern over secondary microplastics (SMPs) stems from their physicochemical evolution from primary microplastics (PMPs), yet the contribution of varying physicochemical transformations to the ultimate environmental risks remains unknown. In this study, a photomechanical degradation process was employed to convert the primary sunscreen-derived microplastics (SDMPs) into secondary SDMPs. While mechanical degradation caused physical fragmentation, photodegradation induced both physical and chemical alterations, introducing surface oxidation, chemical bond scission, and cross-linking to the secondary SDMPs. Employing a combination of alkaline digestion and pyrolysis GC-MS techniques, it was observed that both physical fragmentation and photooxidation led to heightened intracellular sequestration of MPs. Although the bioaccumulated SDMPs could be indicated by the enlarged lysosomes and fragmented mitochondria, toxicity of secondary SDMPs at the cellular level was primarily driven by chemical transformations post-photodegradation. A nontargeted analysis employing high-resolution mass spectrometry identified 46 plastic-associated compounds in the leachate, with photodegradation-induced chemical transformations playing a crucial role in the dissociation of hydrophobic additives and oxidative conversion of leached compounds. The toxicity of the leachate was exacerbated by photodegradation, with mitochondrial fragmentation serving as the primary subcellular biomarker, indicative of leachate toxicity. This study elucidates the pivotal role of photodegradation in augmenting the cytotoxicity of secondary SDMPs, shedding light on the intricate interplay between physicochemical transformations and environmental risks.
2. Sofpironium topical gel, 12.45%, for the treatment of axillary hyperhidrosis: Pooled efficacy and safety results from 2 phase 3 randomized, controlled, double-blind studies.
Across two double-blind phase 3 RCTs (n=701 pooled), sofpironium 12.45% gel significantly improved HDSS-Axillary-7 by ≥2 points and reduced gravimetric sweat versus vehicle, with good tolerability. Findings support once-daily bedtime application in patients ≥9 years with primary axillary hyperhidrosis.
Impact: Provides high-level evidence for an effective, well-tolerated topical therapy addressing an unmet need in primary axillary hyperhidrosis.
Clinical Implications: Consider sofpironium 12.45% gel as a first-line topical option for primary axillary hyperhidrosis in patients ≥9 years, with bedtime application and monitoring for anticholinergic effects.
Key Findings
- Significant pooled improvement in HDSS-Axillary-7 by ≥2 points versus vehicle (P < .0001).
- Greater reduction in gravimetric sweat production at end of treatment versus vehicle (P = .0002).
- Treatment was generally well-tolerated with short-term use over 6 weeks.
Methodological Strengths
- Two pivotal, double-blind, randomized, controlled phase 3 trials with pooled analysis.
- Use of validated co-primary endpoints (HDSS-Axillary-7 and gravimetric sweat).
Limitations
- Short treatment duration and follow-up limit long-term efficacy and safety assessment.
- Generalizability to non-axillary hyperhidrosis or comorbid populations is not established.
Future Directions: Longer-term safety/effectiveness studies, head-to-head comparisons with other topicals or devices, and real-world outcomes in diverse populations.
BACKGROUND: Current treatments for primary axillary hyperhidrosis are insufficient for some patients. Sofpironium topical gel is a retrometabolically-designed topical anticholinergic with rapid metabolism, which is associated with reduced side effects and targeted efficacy. OBJECTIVE: To assess efficacy and safety of sofpironium topical gel for primary axillary hyperhidrosis. METHODS: Cardigan I and Cardigan II were double-blind, randomized, controlled pivotal phase 3 studies of sofpironium topical gel, 12.45%, versus vehicle gel (1:1 randomization) for daily application to the axillae for 6 weeks. RESULTS: The combined Phase 3 studies included 353 subjects in the treatment groups and 348 subjects in the control groups. For the co-primary endpoint of ≥2-point improvement from baseline to end of treatment on Hyperhidrosis Disease Severity Measure-Axillary-7, pooled analyses showed significantly better results for treatment versus control (P < .0001). For the pooled co-primary endpoint of gravimetric sweat production at treatment end, the treatment group had greater reduction in sweat production (P = .0002). Secondary endpoints also showed a statistically significant benefit for sofpironium topical gel versus control. Treatment was well-tolerated. LIMITATIONS: Short treatment and follow-up periods. CONCLUSION: Sofpironium topical gel, 12.45%, applied topically once daily before bedtime is effective and well-tolerated for treatment of primary axillary hyperhidrosis in patients ≥9 years old.
3. A randomised, double-blind clinical study into the effect of zinc citrate trihydrate toothpaste on oral plaque microbiome ecology and function.
In a 6-week double-blind RCT (n=115), zinc citrate toothpaste shifted plaque microbiome composition (e.g., increased Veillonella, decreased Fusobacterium taxa) and reduced predicted glycolysis while increasing pathways linked to gum and systemic health (lysine biosynthesis, nitrate reduction). This provides in-vivo evidence that zinc-containing toothpaste beneficially modulates plaque microbiome ecology and function.
Impact: Demonstrates, via randomized human data, that a consumer oral-care product can beneficially alter microbiome composition and predicted function consistent with health benefits.
Clinical Implications: Supports recommending zinc-containing toothpaste for patients at risk of gingivitis or caries; underscores the need to evaluate long-term clinical outcomes alongside microbiome endpoints.
Key Findings
- Zinc toothpaste altered plaque bacterial communities at community and species levels compared to control.
- Species-level increases in Veillonella and decreases in a Fusobacterium taxon were observed.
- Predicted metagenomic/transcriptomic analyses suggested reduced glycolysis and increased lysine biosynthesis and nitrate reduction.
Methodological Strengths
- Randomized, double-blind, parallel-group design with longitudinal sampling at baseline, 2 and 6 weeks.
- Combined metataxonomics with predicted functional profiling to infer ecological and functional shifts.
Limitations
- Functional inferences were prediction-based rather than from shotgun metagenomics/metatranscriptomics or direct metabolomics.
- Short 6-week duration without hard clinical endpoints (e.g., incident caries/gingivitis).
Future Directions: Incorporate shotgun -omics and metabolomics, extend to longer-term trials with clinical endpoints, and assess systemic effects (nitrate reduction) on cardiometabolic health.
The oral microbiome is a diverse community of microbes residing on all oral surfaces. A balanced oral microbiome is associated with good oral health, and disruption can result in imbalance associated with diseases including gingivitis and dental caries. It is important, therefore, to understand how daily use of oral hygiene products impacts the microbiome. Composition and activity of dental plaque microbiome from 115 participants was analysed after brushing with one of two toothpastes, one containing zinc citrate trihydrate and the other a control toothpaste, in a parallel design. Each participant brushed twice daily for 6-weeks, with samples collected at baseline, 2 and 6-weeks. Metataxonomic analysis demonstrated changes in bacterial communities with use of the zinc toothpaste compared to the control product at community and species level. Increases at the species level were observed for taxa from the genus Veillonella with decrease in a taxon from the genus Fusobacterium for the zinc toothpaste. Analysis of microbiome function based on predicted metagenomic and metatranscriptomic analysis show that use of the zinc toothpaste is associated with an in-vivo reduction in glycolysis, consistent with the mode of action of zinc and, increases in processes linked to gum-health (lysine biosynthesis), and to whole-body health (nitrate reduction). Our findings provide the first understanding of the beneficial modulation of microbiome composition and function by zinc-containing toothpaste in-vivo for oral care benefits.